Literature DB >> 15475200

Stem cell repair of physeal cartilage.

Jae I Ahn1, S Terry Canale, Stephanie D Butler, Karen A Hasty.   

Abstract

To evaluate the ability of cultured mesenchymal stem cells (MSC) to repair physeal defects, MSC-matrix constructs with 5% gelatin (group A), 10% gelatin/Gelfoam (Pharmacia, Peapack, NJ) (group B), and MSC grown in the presence of TGF-beta3 with Gelfoam (group C) were implanted in proximal tibial physeal defects created in 20 immature rabbits. Control groups (untreated partial defect and partial defect treated with Gelfoam) showed bony bar formation with varus deformities of 30 degrees and 28 degrees, respectively. Group A had an average 23 degrees varus deformity with bony bridge formation, and group B had mild varus angulation (average 14 degrees) of the proximal tibia. In group C, there was no significant varus deformity (average 9 degrees), and histologic examination showed that some of the columnation areas interspersed with chondrocytes were irregularly arranged in the matrix. These findings suggest that repair of physeal defects can be enhanced by the implantation of MSC cultured with TGF-beta3.

Entities:  

Mesh:

Year:  2004        PMID: 15475200     DOI: 10.1016/j.orthres.2004.03.012

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  9 in total

1.  [Therapeutic utilization of stem cells in orthopedics].

Authors:  C Chiari; S Walzer; D Stelzeneder; M Schreiner; R Windhager
Journal:  Orthopade       Date:  2017-12       Impact factor: 1.087

Review 2.  Regenerative Medicine Approaches for the Treatment of Pediatric Physeal Injuries.

Authors:  Nichole Shaw; Christopher Erickson; Stephanie J Bryant; Virginia L Ferguson; Melissa D Krebs; Nancy Hadley-Miller; Karin A Payne
Journal:  Tissue Eng Part B Rev       Date:  2017-09-28       Impact factor: 6.389

Review 3.  Stem Cell Considerations for the Clinician.

Authors:  Karen A Hasty; Hongsik Cho
Journal:  Phys Med Rehabil Clin N Am       Date:  2016-11       Impact factor: 1.784

4.  A 3D printed mimetic composite for the treatment of growth plate injuries in a rabbit model.

Authors:  Yangyi Yu; Kristine M Fischenich; Sarah A Schoonraad; Shane Weatherford; Asais Camila Uzcategui; Kevin Eckstein; Archish Muralidharan; Victor Crespo-Cuevas; Francisco Rodriguez-Fontan; Jason P Killgore; Guangheng Li; Robert R McLeod; Nancy Hadley Miller; Virginia L Ferguson; Stephanie J Bryant; Karin A Payne
Journal:  NPJ Regen Med       Date:  2022-10-19

5.  Autologous cartilage and fibrin sealant may be superior to conventional fat grafting in preventing physeal bone bridge formation - a pilot study in porcines.

Authors:  Ahmed A Abood; Bjarne Møller-Madsen; Juan Manuel Shiguetomi-Medina; Hans Stødkilde-Jørgensen; Casper Foldager; Ole Rahbek
Journal:  J Child Orthop       Date:  2020-10-01       Impact factor: 1.548

6.  Application of autologous bone marrow derived mesenchymal stem cells to an ovine model of growth plate cartilage injury.

Authors:  Rosa C McCarty; Cory J Xian; Stan Gronthos; Andrew C W Zannettino; Bruce K Foster
Journal:  Open Orthop J       Date:  2010-06-23

7.  Engineered protein coatings to improve the osseointegration of dental and orthopaedic implants.

Authors:  Jordan Raphel; Johan Karlsson; Silvia Galli; Ann Wennerberg; Christopher Lindsay; Matthew G Haugh; Jukka Pajarinen; Stuart B Goodman; Ryo Jimbo; Martin Andersson; Sarah C Heilshorn
Journal:  Biomaterials       Date:  2016-01-06       Impact factor: 12.479

8.  Preclinical studies on mesenchymal stem cell-based therapy for growth plate cartilage injury repair.

Authors:  Rosa Chung; Bruce K Foster; Cory J Xian
Journal:  Stem Cells Int       Date:  2011-07-26       Impact factor: 5.443

9.  Allogeneic and autogenous transplantations of MSCs in treatment of the physeal bone bridge in rabbits.

Authors:  Ladislav Planka; Petr Gal; Helga Kecova; Jiri Klima; Jana Hlucilova; Eva Filova; Evzen Amler; Petr Krupa; Leos Kren; Robert Srnec; Lucie Urbanova; Jana Lorenzova; Alois Necas
Journal:  BMC Biotechnol       Date:  2008-09-12       Impact factor: 2.563

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.